Table 3.

Prognostic indicators of 5-month survival.

	Hazard ratio	95% Confidence interval	P
Age	0.99	(0.94–1.05)	0.80
Sex	0.90	(0.34–2.37)	0.83
Diabetes	0.40	(0.05–3.08)	0.32
HTN	1.34	(0.43–4.10)	0.62
Hyperlipidemia	1.09	(0.29–4.03)	0.90
CAD	1.49	(0.51–4.36)	0.46
CHF	1.74	(0.52–5.80)	0.36
>200 mg/ <200 mg Amiodarone dose given	1.35	(0.48–3.84)	0.56
Latency period	1.12	(0.90–1.38)	0.33
Cumulative dose	1.001	(0.999–1.003)	0.09
Prothrombin time	1.04	(0.97–1.11)	0.36
Bilirubin (micromole/liter)	0.998	(0.99–1.00)	0.45
AST	1.003	(1.001–1.006)	0.03
ALK P	1.000	(0.999–1.001)	0.98
Albumin	0.99	(0.91–1.09)	0.89
ALT	1.002	(0.999–1.005)	0.21
GGT	1.000	(0.998–1.002)	0.87

Not all studies had data on all the variables.